Reporting Side Effects
Ensuring patient safety is extremely important to Teva and we take the safety of all our medicines seriously.
Teva continuously monitors the safety of all its medicinal products (both drugs and devices) by collecting information about any side effects patients experience. It is vital that the safety of all medicinal products is monitored throughout their marketed life - this is known as pharmacovigilance.
If a medicinal product causes a side effect, you can use the form below to let us know. The more we understand about the effects of our medicinal products, the more can be done to improve the safe use of our medicinal products.
We may contact you to find out more details about your report; however, we are unable to provide medical advice about your condition.
If you are concerned, in any way, about your treatment you should contact your healthcare professional.
Teva Pharmacovigilance Privacy Policy
The information you provide in this form will be recorded by Teva as part of its legal obligations related to our products and will be protected and handled confidentially and in line with applicable data protection laws and Teva’s Privacy Policy.
This information may be shared with other Teva entities and certain authorities to be evaluated and collated with other events (including quality) recorded about that product or active ingredient, in order to assess the benefit – risk balance of the medicines you have used and if needed to update the product information and for the purposes of attending to your request. The information you provide today may be stored outside the EU.
If you do not agree to these uses of your information and wish to object to these processing or wish to access, rectify or delete your personal information please inform our call handler or email EUPrivacy@tevaeu.com. Further information can be found in a more detailed notice here.
If you are not the subject of this report, please ensure that individual who is the subject of the report is aware of this submission, including the possible transmission of his/her personal information.
Date of preparation: April 2023
D: COB-GB-NP-00113 (V1.0) / T: COB-GB-NP-00107 (V1.0) / M: COB-GB-NP-00108 (V1.0)